Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Takashi Oono"'
Autor:
Takahiro Yamasaki, Issei Saeki, Yurika Kotoh-Yamauchi, Ryo Sasaki, Norikazu Tanabe, Takashi Oono, Takashi Matsuda, Takuro Hisanaga, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Yutaka Suehiro, Isao Sakaida
Publikováno v:
Applied Sciences, Vol 11, Iss 4, p 1882 (2021)
Recent success of systemic therapeutic agents, including combination immunotherapy, could promote a change in the treatment strategy in patients with advanced hepatocellular carcinoma (HCC). Although hepatic arterial infusion chemotherapy (HAIC) is a
Externí odkaz:
https://doaj.org/article/b213dda1a9c04699bbb481c329b4615e
Autor:
Yurika Kotoh, Issei Saeki, Takahiro Yamasaki, Ryo Sasaki, Norikazu Tanabe, Takashi Oono, Takashi Matsuda, Takuro Hisanaga, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida
Publikováno v:
Applied Sciences, Vol 10, Iss 16, p 5403 (2020)
Previous studies have reported prognostic factors for hepatocellular carcinoma (HCC) patients receiving lenvatinib; however, no studies have evaluated the effects of both handgrip strength and skeletal muscle mass on the clinical outcomes. Therefore,
Externí odkaz:
https://doaj.org/article/b3b9f4a41694455eb0bc96deb80ae6c9
Autor:
Tsuyoshi Ishikawa, Maho Egusa, Tsuyoshi Fujioka, Natsuko Nishiyama, Daiki Kawamoto, Ryo Sasaki, Tatsuro Nishimura, Norikazu Tanabe, Takashi Oono, Issei Saeki, Taro Takami
Publikováno v:
Journal of Gastroenterology. 58:246-256
We previously reported liver stiffness (LS) as a prognostic predictor of portosystemic shunt (PSS) occlusion. This study aims to reinvestigate the predictive factors of the model for end-stage liver disease-sodium (MELD-Na) score amelioration followi
Autor:
Norikazu Tanabe, Issei Saeki, Yuki Aibe, Takashi Matsuda, Tadasuke Hanazono, Maiko Nishi, Isao Hidaka, Shinya Kuwashiro, Shogo Shiratsuki, Keiji Matsuura, Maho Egusa, Natsuko Nishiyama, Tsuyoshi Fujioka, Daiki Kawamoto, Ryo Sasaki, Tatsuro Nishimura, Takashi Oono, Takuro Hisanaga, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Takahiro Yamasaki, Taro Takami
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 2927
Despite the promising efficacy of atezolizumab plus bevacizumab (atezo/bev), some patients with unresectable hepatocellular carcinoma (HCC) experience disease progression. This retrospective study, which included 154 patients, aimed to evaluate predi
Autor:
Issei Saeki, Yutaka Suehiro, Yurika Yamauchi, Tomomi Hoshida, Norikazu Tanabe, Takashi Oono, Daiki Kawamoto, Tatsuro Nishimura, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Mototsugu Shimokawa, Akihiro Tamori, Norifumi Kawada, Yasuyuki Tamai, Motoh Iwasa, Hayato Nakagawa, Hiroaki Nagano, Taro Takami, Takahiro Yamasaki
Publikováno v:
Hepatology International.
Autor:
Yurika Yamauchi, Issei Saeki, Takahiro Yamasaki, Maho Egusa, Natsuko Nishiyama, Tsuyoshi Fujioka, Daiki Kawamoto, Tatsuro Nishimura, Norikazu Tanabe, Takashi Oono, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Yoshio Marumoto, Satoshi Matsukuma, Yoshitaro Shindo, Yukio Tokumitsu, Sota Yoshimine, Junichi Murakami, Toshiki Tanaka, Sotai Kimura, Yoshinobu Hoshii, Kimikazu Hamano, Hiroaki Nagano, Taro Takami
Publikováno v:
Hepatology Research.
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 36:29-35
Autor:
Takashi Oono, Reo Kawano, Isao Hidaka, Tsuyoshi Ishikawa, Takahiro Yamasaki, Miyuki Masui, Toshihiko Matsumoto, Aki Fujinaga, Takuro Hisanaga, Taro Takami, Isao Sakaida, Issei Saeki, Yoshio Marumoto
Publikováno v:
Kanzo. 62:448-455
Autor:
Ryo Sasaki, Hiroshi Itoh, Yurika Kotoh, Isao Hidaka, Taro Takami, Issei Saeki, Tsuyoshi Ishikawa, Isao Sakaida, Takashi Matsuda, Takashi Oono
Publikováno v:
Kanzo. 62:349-356
Autor:
Terumi Hamao, Takuya Iwamoto, Sumire Harano, Takashi Oono, Issei Saeki, Tsuyoshi Ishikawa, Isao Hidaka, Isao Sakaida, Taro Takami
Publikováno v:
Kanzo. 61:434-437